Lilly Completes Acquisition of Centessa to Advance Sleep Disorder Therapies
Lilly expands its neuroscience portfolio with the acquisition of Centessa Pharmaceuticals to accelerate treatments for narcolepsy and related sleep disorders.
Centessa Pharmaceuticals | 26/06/2026 | By News Bureau
Nxera Pharma to Receive USD 4.6 Million from Centessa
Nxera Pharma has been expecting to receive USD 4.6 million in milestone payments from Centessa Pharmaceuticals under a license agreement regarding Nxera technology used to help design Centessa’s novel orexin receptor 2 (OX2R) agonist, ORX750.
Centessa Pharmaceuticals | 30/05/2024 | By Aishwarya | 541
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy